GKB65.00

GKB Ophthalmics Limited

· Pharma & Health
₹ CrorePeersFABTECHLAXMIDENTLTARSONSFISCHER
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.5
+ Finance Costs1.5
+ Interest Income-0.0
+ Dividend Income-1.6
Changes in Working Capital
+ Inventories-0.7
+ Trade Receivables — Current1.1
+ Trade Payables — Current-0.8
Cash from Operating Activities
Profit Before Tax (per I/S)-3.0
+ Income Taxes Paid0.0
Cash from Operating Activities-1.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.8
+ Dividends Received — Investing0.7
+ Interest Received — Investing0.0
Cash from Investing Activities2.4
Cash from Financing Activities
+ Repayment of Borrowings0.6
+ Interest Paid1.5
+ Dividends Paid0.0
Cash from Financing Activities-2.0
Net Changes in Cash-0.8
Reference Items
EBITDA-1.1
EBITDA Margin %-3.95
Free Cash Flow (CFO − Capex)-2.0
Cash Flow to Net Income0.40
Cash Paid for Taxes0.0
Cash Paid for Interest1.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.